Madison Street Partners’s Filana Therapeutics FLNA Stock Holding History

Madison Street Partners’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-268,029	Closed	-$7.34M	–	31
2014 Q3	$7.34M	Buy	268,029 +24,063	+10%	+$731K	11.12%	1
2014 Q2	$9.82M	Buy	243,966 +31,674	+15%	+$1.17M	9.95%	1
2014 Q1	$8.17M	Buy	212,292 +72,770	+52%	+$2.57M	5.73%	2
2013 Q4	$4.75M	Buy	139,522 +15,738	+13%	+$418K	4.45%	6
2013 Q3	$2.36M	Sell	123,784 -5,026	-4%	-$87.9K	2.77%	8
2013 Q2	$1.99M	Buy	+128,810	New	+$2.72M	2.08%	15

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Madison Street Partners's FLNA Position: Q4 2014 in Review

Madison Street Partners sold out of Filana Therapeutics (FLNA) in Q4 2014, closing a stake of 268,029 shares — an estimated $7.34M sold.

Madison Street Partners first reported a position in FLNA in Q2 2013 and held it in 6 quarters. The position peaked at $9.82M in Q2 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q4 2014.

Madison Street Partners reported no remaining Filana Therapeutics position as of Q4 2014 after selling out during the quarter.
Madison Street Partners sold 268,029 Filana Therapeutics shares in Q4 2014, an estimated $7.34M.
Madison Street Partners first reported a position in Filana Therapeutics in Q2 2013 and held it in 6 quarters.
Madison Street Partners's Filana Therapeutics position peaked at $9.82M in Q2 2014.
66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2014.

Based on Madison Street Partners's 13F filing for Q4 2014, filed 14 Jan 2015.